????????????							??????
??????????????????????????????????????????????????????????????????????????????????????

??????????????????????						??????????????

?????????????????????????????

•	??????????????????????????????????
•	????????????????????????????????
•	??????????????????????????????

*	Igm anti-HAV response usually peaks within the first month of illness and persists  throughout the first three to six months, declining to nondetectable levels within 12 months. 
•	Igm anti-HAV is not detected in normal subjects whether or not they have IgG antibody to hepatitis A Virus (IgG anti HAV) in their serum from previous HAV exposure. 
•	For diagnostic purposes, IgM anti-HAV reactivity should be correlated with patient history and other hepatitis markers for diagnosis of past or present infection, or vaccination against HAV. 

-------------------------------------------------------------------------------------------------------

?????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????--------------------------------------------------------------------------------------
  TEST NAME 							RESULT
--------------------------------------------------------------------------------------

        ANTI HAV  IgG					NON - REACTIVE

	INTERPRETATION OF RESULTS
•	Values  1.001 to 3.000  -- NON REACTIVE
•	Values 0.000 to 1.000   -- REACTIVE

 1. AxSYM HAVAB 2.0 is a microparticle enzyme immunoassay (MEIA) for the detection of total antibody to hepatitis A Virus (anti-HAV) in human serum or        plasma.  A test for anti-HAV is indicated as an aid in the diagnosis of previous or ongoing hepatitis A viral infection, or for the detection of anti-HAV after vaccination.  

2. The presence of anti- HAV in human serum or plasma is indicative of past or present infection with HepatitisA virus (HAV) or vaccination against HAV      Anti-HAV is detectable during the acute stage of illness (IgM anti-HAV) and may persist for years after recovery (IgG anti-HAV).Virus specific IgM              anti-HAV is the most reliable marker for determining the acute stage of disease.  The test for total anti-HAV is primarily used to determine pervious exposure to HAV. Increasing titres of total anti-HAV in sequential patient samples may indicate an ongoing hepatitis A viral infection. 
-------------------------------------------------------------------------------------------------------

Done By AXSYM Assay (ABOTT LABORATORIES)